泌尿器デバイス：市場洞察・競合環境・市場予測 (～2030年)

泌尿器デバイスの市場規模は、2023年の91億7,000万米ドルから、予測期間中はCAGR 6.78％で推移し、2030年には135億6,000万米ドルの規模に成長すると予測されています。

泌尿器デバイスの市場は、癌や前立腺肥大症 (BPH) を含む慢性疾患の患者数の増加、そのような状態に陥りやすい老年人口の増加、製品開発における技術進歩、低侵襲処置が好まれる傾向の拡大などによって大きく成長しています。

泌尿器デバイス：市場力学

Global Cancer Observatory (2024年) が提供したデータによると、2022年の前立腺癌患者数は欧州が473,011例、アジアが386,424例、ラテンアメリカ・カリブ海諸国 (LAC) が225,985例、アフリカが103,050例でした。

さらに、直腸癌はアジアが417,357例、欧州が181,701例、中南米カリブ海諸国が43,036例、アフリカが27,672例でした。

National Institute of Health (2024) によると、前立腺肥大症の現在の有病率は60歳代で50～60％、70歳以上では80～90％と世界的に増加しています。

さらに、WHO (2021年) は、2015年から2050年の間に、60歳以上の高齢者は12～22％から倍増し、2050年には21億人に達すると述べています。さらに、2030年には6人に1人が60歳以上になると報告されています。

人口の高齢化に伴い、前立腺癌、前立腺肥大症、直腸癌の有病率が増加しているため、泌尿器デバイスに対する大きな需要が生じています。これらの疾患はしばしば泌尿器系の合併症を引き起こすため、高度な治療オプションに対するニーズが高まっています。医療技術の革新と患者の予後改善への注目の高まりから、医療システムは尿路閉塞の効果的な管理を優先しており、このことも市場の拡大に寄与しています。

製品タイプ別では、透析デバイスの部門が2023年に大きな収益シェアを占めると予想されています。この部門の急成長は、透析デバイスの特徴に起因しています。

先進的な透析デバイスには、遠隔監視機能、リアルタイムのデータ収集、さまざまな治療パラメータの自動化などの機能が搭載されていることが多く、安全性と使いやすさが向上しています。さらに、患者の自由度を高め、生活の質を向上させるために、ウェアラブル透析デバイスの研究も進められています。透析デバイスの用途は、慢性腎臓病管理だけでなく、急性腎障害、薬物過剰摂取時の緊急解毒、最終腎臓病患者の腎移植への橋渡しなど、多岐にわたっています。

地域別では、北米地域が2023年の市場を独占し、予測期間中も同様の見通しと予想されています。この背景には、腎臓結石の増加、前立腺癌の有病率の増加、効果的な管理ソリューションに対する需要の高まりがあり、技術の進歩、規制当局の承認、主要企業の市場での大きな存在感、医療インフラへの継続的な投資、革新的な製品開発が予測期間中の市場を牽引するとみられています。

当レポートでは、世界の泌尿器デバイスの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 泌尿器デバイス市場レポート：イントロダクション

• 調査範囲
• 市場の分類
• 市場の想定

第2章 泌尿器デバイス市場：エグゼクティブサマリー

• 市場概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 泌尿器デバイス市場：主要要因分析

• 市場促進要因
  • 慢性疾患の増加
  • 高齢化人口の増加
  • 腎臓結石の増加
  • 低侵襲手術への関心の高まり
• 市場抑制要因と課題
  • 血尿に伴う周囲組織の破壊
  • 結石破片残留のリスク
• 市場機会
  • 生体吸収性材料の開発
  • 不正確な診断や治療の困難さを排除するための高度な機器の必要性

第6章 泌尿器デバイス市場：ポーターのファイブフォース分析

第7章 泌尿器デバイス市場の評価

• 製品タイプ別
  • 透析デバイス
  • 内視鏡
  • 尿力学システム
  • 尿管ステント
  • その他
• エンドユーザー別
  • 病院
  • 専門クリニック
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 泌尿器デバイス市場：企業・製品プロファイル

• Olympus Corporation
• Baxter
• Boston Scientific Corporation
• B. Braun Melsungen AG
• Nipro Corporation
• Medtronic
• Cook
• BestMedical
• Potent Medical
• Laborie
• Well Lead Medical Co.,Ltd
• Amecath Medical Technologies
• NIKKISO CO., LTD
• Asahi Kasei Medical
• Applied Medical Resources Corporation
• Advin Urology
• DirexGroup
• STORZ MEDICAL AG
• Richard Wolf GmbH
• Fresenius Medical Care

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項・問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Urology Devices Market in Global (2021-2030)
• Table 3: Urology Devices Market in Global by Product Type (2021-2030)
• Table 4: Urology Devices Market in Global by End-User (2021-2030)
• Table 5: Urology Devices Market in Global by Geography (2021-2030)
• Table 6: Urology Devices Market in North America (2021-2030)
• Table 7: Urology Devices Market in the United States (2021-2030)
• Table 8: Urology Devices Market in Canada (2021-2030)
• Table 9: Urology Devices Market in Mexico (2021-2030)
• Table 10: Urology Devices Market in Europe (2021-2030)
• Table 11: Urology Devices Market in France (2021-2030)
• Table 12: Urology Devices Market in Germany (2021-2030)
• Table 13: Urology Devices Market in United Kingdom (2021-2030)
• Table 14: Urology Devices Market in Italy (2021-2030)
• Table 15: Urology Devices Market in Spain (2021-2030)
• Table 16: Urology Devices Market in the Rest of Europe (2021-2030)
• Table 17: Urology Devices Market in Asia-Pacific (2021-2030)
• Table 18: Urology Devices Market in China (2021-2030)
• Table 19: Urology Devices Market in Japan (2021-2030)
• Table 20: Urology Devices Market in India (2021-2030)
• Table 21: Urology Devices Market in Australia (2021-2030)
• Table 22: Urology Devices Market in South Korea (2021-2030)
• Table 23: Urology Devices Market in Rest of Asia-Pacific (2021-2030)
• Table 24: Urology Devices Market in the Rest of the World (2021-2030)
• Table 25: Urology Devices Market in the Middle East (2021-2030)
• Table 26: Urology Devices Market in Africa (2021-2030)
• Table 27: Urology Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Urology Devices Market in Global (2021-2030)
• Figure 3: Urology Devices Market in Global by Product Type (2021-2030)
• Figure 4: Urology Devices Market in Global by End-User (2021-2030)
• Figure 5: Urology Devices Market in Global by Geography (2021-2030)
• Figure 6: Urology Devices Market in North America (2021-2030)
• Figure 7: Urology Devices Market in the United States (2021-2030)
• Figure 8: Urology Devices Market in Canada (2021-2030)
• Figure 9: Urology Devices Market in Mexico (2021-2030)
• Figure 10: Urology Devices Market in Europe (2021-2030)
• Figure 11: Urology Devices Market in France (2021-2030)
• Figure 12: Urology Devices Market in Germany (2021-2030)
• Figure 13: Urology Devices Market in United Kingdom (2021-2030)
• Figure 14: Urology Devices Market in Italy (2021-2030)
• Figure 15: Urology Devices Market in Spain (2021-2030)
• Figure 16: Urology Devices Market in the Rest of Europe (2021-2030)
• Figure 17: Urology Devices Market in Asia-Pacific (2021-2030)
• Figure 18: Urology Devices Market in China (2021-2030)
• Figure 19: Urology Devices Market in Japan (2021-2030)
• Figure 20: Urology Devices Market in India (2021-2030)
• Figure 21: Urology Devices Market in Australia (2021-2030)
• Figure 22: Urology Devices Market in South Korea (2021-2030)
• Figure 23: Urology Devices Market in Rest of Asia-Pacific (2021-2030)
• Figure 24: Urology Devices Market in the Rest of the World (2021-2030)
• Figure 25: Urology Devices Market in the Middle East (2021-2030)
• Figure 26: Urology Devices Market in Africa (2021-2030)
• Figure 27: Urology Devices Market in South America (2021-2030)
• Figure 28: Market Drivers
• Figure 29: Market Barriers
• Figure 30: Marker Opportunities
• Figure 31: PORTER'S Five Force Analysis

Urology Devices Market by Product Type (Dialysis Devices, Endoscopes [Ureteroscopes, Nephroscopes, Resectoscopes, and Others], Urodynamic Systems, Uretral Stents, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of chronic disorders and the rising product developmental activities across the globe

The urology devices market was valued at USD 9.17 billion in 2023, growing at a CAGR of 6.78% during the forecast period from 2024 to 2030 to reach USD 13.56 billion by 2030. The urology devices market is growing significantly due to the increasing cases of chronic disorders including cancers and benign prostatic hyperplasia (BPH), rising geriatric population prone to such conditions, technological advancements in product development, growing preference of minimally invasive procedures that are expected to escalate the demand for urology devices during the forecast period from 2024 to 2030.

Urology Devices Market Dynamics:

According to the data provided by the Global Cancer Observatory (2024), in 2022, Europe accounted for 473,011 prostate cancer cases, Asia accounted for 386,424 prostate cancer cases, Latin American and the Caribbean (LAC) accounted for 225,985 prostate cancer cases, and Africa accounted for 103,050 prostate cancer cases.

Furthermore, it stated that Asia accounted for 417,357 rectum cancer cases, Europe accounted for 181,701 rectum cancer cases, LAC accounted for 43,036 rectum cancer cases, and Africa accounted for 27,672 rectum cancer cases.

According to the National Institute of Health (2024), the current prevalence of benign prostatic hyperplasia (BPH) is 50% to 60% for people in their 60s, increasing to 80% to 90% of those older than 70 years of age, globally.

Moreover, the World Health Organization (2021) further stated between 2015 and 2050, people falling between 60 years and above will be doubled from 12-22%, and will eventually reach 2.1 billion by the year 2050, globally. Moreover, by 2030, 1 in 6 people will be aged 60 years or above.

The increasing prevalence of prostate cancer, BPH, and rectal cancer, with aging populations, is creating a significant demand for urology devices. As these conditions often lead to urinary complications, the need for advanced treatment options is rising. The global aging trend, with more people reaching older age groups where these conditions are more common, further amplifies the market demand. Innovations in medical technology and a growing focus on improving patient outcomes are also contributing to the expansion of this market, as healthcare systems prioritize effective management of urinary tract obstructions.

Therefore, the factors stated above collectively will drive the overall urology devices market during the forecast period from 2024 to 2030.

However, the disruption of surrounding tissue associated with hematuria and risks of stone fragment retention, among others may limit their end-user base, thus acting as key constraints limiting the growth of the urology devices market.

Urology Devices Market Segment Analysis:

Urology Devices Market by Product Type (Dialysis Devices, Endoscopes [Ureteroscopes, Nephroscopes, Resectoscopes, and Others], Urodynamic Systems, Uretral Stents, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of urology devices, the dialysis devices category is expected to have a significant revenue share in the year 2023. The rapid growth of this product category can be attributed to the features of the dialysis devices.

Dialysis devices are essential medical equipment used to filter and purify blood for individuals whose kidneys can no longer perform these functions efficiently. The primary feature of dialysis devices is their ability to remove waste products, excess fluids, and toxins from the bloodstream, mimicking the natural functions of the kidneys.

Advanced dialysis machines often include features like remote monitoring capabilities, real-time data collection, and automation of various treatment parameters, enhancing safety and ease of use. Additionally, wearable dialysis devices are being explored to offer patients more freedom and improved quality of life. Applications of dialysis devices extend beyond chronic kidney disease management to include use in acute kidney injury, emergency detoxification for drug overdose cases, and as a bridge to kidney transplant for end-stage renal disease patients.

Therefore, owing to the above-mentioned factors, the demand for the dialysis devices category upsurges, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the urology devices market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall urology devices market:

Among all the regions, North America is expected to dominate the urology devices market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. This is due to the increasing instance of kidney stones, growing prevalence of prostate cancer underscoring the increased demand for effective management solutions, enhanced by technological advancements, regulatory approvals, and significant market presence of leading companies, continued investment in healthcare infrastructure and innovative product developments that are expected to drive the market for urology devices during the forecast period from 2024 to 2030.

According to the American Urological Association (2024), nearly 1 in 11 individuals in the US experience kidney stone at some point in their lives, and evidence suggests that the incidence of kidney stones is increasing.

According to Globocan (2024), in 2022, the US accounted for 230,125 cases of prostate cancer and Canada accounted for 25,560 cases of prostate cancer. Additionally, it further stated that by 2050, prostate cancer will reach to 346,000 cases in the North American region.

The rising incidence of kidney stones and prostate cancer is driving the demand for urology devices. As more individuals experience these conditions, there is a growing need for effective interventions to manage urinary blockages, making this a rapidly expanding market.

Additionally, in North America and at the global level the US represents the largest market worldwide supported by the developed healthcare infrastructure and strong adoption of technologically advanced products owing to the rise in healthcare expenditure by the government.

Rising product developmental activities by regulatory bodies in the region will further boost the market for urology devices. For example in April 2024, Olympus Corporation announced the FDA 510(k) clearance for its RenaFlex single-use ureteroscope system. RenaFlex offers access and visualization in the urinary tract to diagnose and treat urinary diseases and disorders, such as kidney stones.

Moreover, the presence of key players such as Boston Scientific Corporation, B. Braun Melsungen AG, Cook, among others in the region with their strong distribution networks ensure widespread availability and accessibility of these devices increasing their revenue shares in the market is also a driving factor for the urology devices market as they hold a significant revenue share in the region.

Therefore, the interplay of all the aforementioned factors above would provide a conducive growth environment for the North America region in the urology devices market.

Urology Devices Market key players:

Some of the key market players operating in the Urology Devices market include Olympus Corporation, Baxter, Boston Scientific Corporation, B. Braun Melsungen AG, Nipro Corporation, Medtronic, Cook, BestMedical, Potent Medical, Laborie, Well Lead Medical Co.,Ltd, Amecath Medical Technologies, NIKKISO CO., LTD, Asahi Kasei Medical, Applied Medical Resources Corporation, Advin Urology, DirexGroup, STORZ MEDICAL AG, Richard Wolf GmbH, Fresenius Medical Care, and others.

Recent Developmental Activities in the Urology Devices Market:

• In January 2022, Applaud Medical, Inc received the Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). The Acoustic Enhancer technology is designed to be used in conjunction with Ureteroscopy with Laser Lithotripsy (URS-LL).
• In March 2021, Dornier MedTech GmbH became the world's first integrated urology company to be certified by the European Union's Medical Device Regulation (MDR). Dornier achieved the certification for its Class IIb products: Dornier Delta(R) III, one of the most powerful lithotripters that utilize Dornier's Extracorporeal Shock Wave Lithotripsy (ESWL) technology; and the Dornier UIMS(TM), a state-of-the-art information management software providing enhanced imaging and efficiency to support clinicians in treating kidney stones.
• In January 2021, the US Food and Drug Administration granted the regulatory approval to Quanta Dialysis Technologies Ltd for their product- hemodialysis system SC+. The device is a portable system which is capable of offering dialysis care comparable to full-sized dialysis equipment in a range of care settings.

Key Takeaways from the Urology Devices Market Report Study

• Market size analysis for current urology devices market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the urology devices market
• Various opportunities available for the other competitors in the urology devices market space
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current urology devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for urology devices market growth in the coming future?

Target audience who can be benefited from this Urology Devices Market Report Study

• Urology devices product providers
• Research organizations and consulting companies
• Urology devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in urology devices
• Various end-users who want to know more about the urology devices market and the latest developments in the urology devices market

Frequently Asked Questions for the Urology Devices Market:

1. What are Urology Devices?

• The urology devices encompass a variety of devices which are used in the treatment of indications specific to the urogenital systems. These devices include lithotripsy systems, urodynamic devices, and dialysis devices among others.

2. What is the market for Urology Devices?

• The urology devices market was valued at USD 9.17 billion in 2023, growing at a CAGR of 6.78% during the forecast period from 2024 to 2030 to reach USD 13.56 billion by 2030.

3. What are the drivers for the Urology Devices market?

• The urology devices market is growing significantly due to the increasing cases of chronic disorders including cancers and benign prostatic hyperplasia (BPH), rising geriatric population prone to such conditions, technological advancements in product development, growing preference of minimally invasive procedures are factors that are expected to escalate the demand for urology devices during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Urology Devices market?

• Some of the key market players operating in the urology devices market include Olympus Corporation, Baxter, Boston Scientific Corporation, B. Braun Melsungen AG, Nipro Corporation, Medtronic, Cook, BestMedical, Potent Medical, Laborie, Well Lead Medical Co., Ltd, Amecath Medical Technologies, NIKKISO CO., LTD, Asahi Kasei Medical, Applied Medical Resources Corporation, Advin Urology, DirexGroup, STORZ MEDICAL AG, Richard Wolf GmbH, Fresenius Medical Care, and others.

5. Which region has the highest share in the Urology Devices market?

• Among all the regions, North America is estimated to hold a significant revenue share in the urology devices market. This is due to the increasing instances of kidney stones, and growing prevalence of prostate cancer underscoring the increased demand for effective management solutions, enhanced by technological advancements, regulatory approvals, and significant market presence of leading companies, continued investment in healthcare infrastructure, and innovative product developments that are expected to drive the market for urology devices during the forecast period from 2024 to 2030.

Table of Contents

1. Urology Devices Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Urology Devices Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Urology Devices Market Key Factors Analysis

• 5.1. Urology Devices Market Drivers
  • 5.1.1. Rising cases of chronic disorders
  • 5.1.2. Growing geriatric population
  • 5.1.3. Rising instances of kidney stones
  • 5.1.4. Increasing preference for minimally invasive procedures
• 5.2. Urology Devices Market Restraints and Challenges
  • 5.2.1. Disruption of surrounding tissue associated with hematuria
  • 5.2.2. Risk of stone fragment retention
• 5.3. Urology Devices Market Opportunities
  • 5.3.1. Development of bioresorbable materials
  • 5.3.2. Need for advanced devices to eliminate inaccurate diagnosis and difficulties in treatment

6. Urology Devices Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Urology Devices Market Assessment

• 7.1. By Product Type
  • 7.1.1. Dialysis Devices
  • 7.1.2. Endoscopes
    • 7.1.2.1. Ureteroscopes
    • 7.1.2.2. Nephroscopes
    • 7.1.2.3. Resectoscopes
    • 7.1.2.4. Others
  • 7.1.3. Urodynamic Systems
  • 7.1.4. Uretral Stents
  • 7.1.5. Others
• 7.2. By End-User
  • 7.2.1. Hospitals
  • 7.2.2. Specialty Clinics
  • 7.2.3. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Urology Devices Market Size in USD million (2021-2030)
    • 7.3.1.2. Canada Urology Devices Market Size in USD million (2021-2030)
    • 7.3.1.3. Mexico Urology Devices Market Size in USD million (2021-2030)
  • 7.3.2. Europe
    • 7.3.2.1. France Urology Devices Market Size in USD million (2021-2030)
    • 7.3.2.2. Germany Urology Devices Market Size in USD million (2021-2030)
    • 7.3.2.3. United Kingdom Urology Devices Market Size in USD million (2021-2030)
    • 7.3.2.4. Italy Urology Devices Market Size in USD million (2021-2030)
    • 7.3.2.5. Spain Urology Devices Market Size in USD million (2021-2030)
    • 7.3.2.6. Rest of Europe Urology Devices Market Size in USD million (2021-2030)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Urology Devices Market Size in USD million (2021-2030)
    • 7.3.3.2. Japan Urology Devices Market Size in USD million (2021-2030)
    • 7.3.3.3. India Urology Devices Market Size in USD million (2021-2030)
    • 7.3.3.4. Australia Urology Devices Market Size in USD million (2021-2030)
    • 7.3.3.5. South Korea Urology Devices Market Size in USD million (2021-2030)
    • 7.3.3.6. Rest of Asia-Pacific Urology Devices Market Size in USD million (2021-2030)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Urology Devices Market Size in USD million (2021-2030)
    • 7.3.4.2. Africa Urology Devices Market Size in USD million (2021-2030)
    • 7.3.4.3. South America Urology Devices Market Size in USD million (2021-2030)

8. Urology Devices Market Company and Product Profiles

• 8.1. Olympus Corporation
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Baxter
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Boston Scientific Corporation
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. B. Braun Melsungen AG
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Nipro Corporation
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Medtronic
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Cook
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. BestMedical
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Potent Medical
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Laborie
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Well Lead Medical Co.,Ltd
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Amecath Medical Technologies
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. NIKKISO CO., LTD
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Asahi Kasei Medical
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Applied Medical Resources Corporation
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Advin Urology
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. DirexGroup
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. STORZ MEDICAL AG
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Richard Wolf GmbH
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Fresenius Medical Care
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us